Nanotechnology in Medicine - Thematic Research
Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the ability to target specific cells or tissues. These materials are produced on a nanoscale level and are safe to introduce into the body. Applications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs that will help medical professionals treat various diseases.
In addition to targeted delivery of therapeutics, nanotechnology can also be used to release drugs in a controlled manner. This can result in improved outcomes for patients due to a reduction in toxicity, more efficient delivery of therapeutic molecules, and longer lifetime of drugs within the body.
This report focuses on nanotechnology and nanomedicines that are currently approved by the FDA.
Components of the report include -
Reasons to Buy
- Key Players - identify big players in nanomedicine.
- Trends - identify key trends expected to occur in the nanotechnology industry over the next 12 to 24 months. These are classified into technology/scientific trends, macroeconomic trends, and regulatory trends.
- Industry Analysis - identify the impact of nanotechnology across major markets.
- Value Chain - identify the various uses of nanotechnologies in medicine.
- Develop and design your corporate strategies through an in-house expert analysis of nanotechnology and the impact on medicine.
- Develop business strategies by understanding the primary ways in which nanotechnology is changing the delivery of medicine.
- Stay up to date on the industry’s major players in nanotechnology and where they sit in the value chain.
- Identify emerging industry trends in nanotechnology to gain a competitive advantage.
- Nanotechnology in Medicine is on the Rise
- Leaders and Disruptors in Nanomedicine
- Table Figure 1: Who are the leaders and disruptors in the nanomedicine value chain?
- Technology/Scientific Trends
- Table Technology/Scientific Trends
- Macroeconomic Trends
- Table Macroeconomic Trends
- Regulatory Trends
- Industry Analysis
- Market Segmentation
- Table Figure 2: Nanotechnology in Medicine: Three Major Market Segments
- Table Figure 3: Indications for FDA-Approved Nanomedicines Using Liposomes
- Table Figure 4: Global Microbubble Market Value
- Table Figure 5: US Microbubble Market Value
- Table Figure 6: Composition of FDA-Approved Nanomedicines Using Nanoparticles
- Generation of Revenue
- Table Figure 7: US Nanomedicine ASPs (2019)
- Competitive Analysis
- Case Studies
- Case Study 1: Jazz Pharmaceutical's Vyxeos
- Table Figure 8: Global Vyxeos Market Value
- Case Study 2: Novo Nordisk's Rebinyn
- Table Figure 9: Global Rebinyn Market Value
- Mergers and Acquisitions
- Table Mergers and Acquisitions
- Table Figure 10: Timeline of FDA-Approved Nanomedicines
- Clinical Trials
- Table Figure 11: Nanotechnology in Medicine Clinical Trials – Oncology
- Value Chain
- Table Figure 12: The Nanomedicine Value Chain
- COVID-19 Impact on Nanotechnology in Medicine
- COVID-19's impact will be short-term and minimal
- COVID-19's impact will provide an opportunity for some companies and will affect future product development
- Public Companies
- Private Companies
- Appendix: Our thematic research methodology
- Viewing the world's data by themes makes it easier to make important decisions
- Traditional research does a poor job of picking winners and losers
- That is why we developed our "thematic engine"
- How do we create our sector scorecards?
- Table Figure 13:Our five-step approach for generating a sector scorecard
- What is in our sector scorecards?
- How do we score companies in our thematic screen?
- How our research reports fit into our overall thematic research ecosystem
- About GlobalData
- Contact us
- Client Services